HealthDay on MSN10h
FDA Approves Tablet Form of Evrysdi for Spinal Muscular Atrophy
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Bioscience industry in Oregon outpaces overall job growth
Oregon's bioscience sector has been growing faster than the overall economy, but proposed federal budget cuts could slow its ...
Los Angeles Business Journal1d
City of Hope Is Leader in Field
One of the key launch points for the modern biotechnology industry was not in the Bay Area or San Diego or Cambridge, ...
'Hearts In San Francisco' Sculpture Donated To Downtown
The bright red heart-shaped sculpture was installed downtown at the corner of Main and Parker streets this month through a partnership between the San Francisco General Hospital Foundation, Genentech ...
Stopping Alzheimer’s Before It Starts: Landmark Trial Enrolls First Participants
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...
Healio4d
FDA approves Evrysdi tablets for spinal muscular atrophy
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
STAT4d
Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
SMA4d
FDA approves new tablet version of oral SMA treatment Evrysdi
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Monthly Prescribing Reference4d
New Tablet Formulation of SMA Therapy Evrysdi Gets FDA Approval
The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.
BioSpace4d
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
FierceBiotech5d
Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’
Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...
The American Journal of Managed Care6d
Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval
The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...